Industry Growth Insights published a new data on “OTC Cough and Cold and Allergy Medicine Market”. The research report is titled “OTC Cough and Cold and Allergy Medicine Market research by Types (Antihistamine, Expectorants, Bronchodialators, Antibiotics, Others), By Applications (Online, Offline), By Players/Companies Sanofi-Aventis, Johnson and Johnson, Reckitt Benckiser Group, Novartis, GlaxoSmithKline, AstraZaneca, Pfizer, Sun Pharmaceutical Industries, Prestige Brands Holdings, Procter and Gamble, Bristol-Myers Squib, Merck and Co., Allergen”.
Scope Of The Report
Report Attributes
Report Details
Report Title
OTC Cough and Cold and Allergy Medicine Market Research Report
By Type
Antihistamine, Expectorants, Bronchodialators, Antibiotics, Others
By Application
Online, Offline
By Companies
Sanofi-Aventis, Johnson and Johnson, Reckitt Benckiser Group, Novartis, GlaxoSmithKline, AstraZaneca, Pfizer, Sun Pharmaceutical Industries, Prestige Brands Holdings, Procter and Gamble, Bristol-Myers Squib, Merck and Co., Allergen
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
229
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global OTC Cough and Cold and Allergy Medicine Market Report Segments:
The global OTC Cough and Cold and Allergy Medicine market is segmented on the basis of:
Types
Antihistamine, Expectorants, Bronchodialators, Antibiotics, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Online, Offline
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi-Aventis
- Johnson and Johnson
- Reckitt Benckiser Group
- Novartis
- GlaxoSmithKline
- AstraZaneca
- Pfizer
- Sun Pharmaceutical Industries
- Prestige Brands Holdings
- Procter and Gamble
- Bristol-Myers Squib
- Merck and Co.
- Allergen
Highlights of The OTC Cough and Cold and Allergy Medicine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antihistamine
- Expectorants
- Bronchodialators
- Antibiotics
- Others
- By Application:
- Online
- Offline
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the OTC Cough and Cold and Allergy Medicine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
OTC cough and cold and allergy medicines are over-the-counter medications that are used to treat symptoms of the common cold or allergies. These medications include decongestants, antihistamines, and other respiratory remedies.
Some of the key players operating in the otc cough and cold and allergy medicine market are Sanofi-Aventis, Johnson and Johnson, Reckitt Benckiser Group, Novartis, GlaxoSmithKline, AstraZaneca, Pfizer, Sun Pharmaceutical Industries, Prestige Brands Holdings, Procter and Gamble, Bristol-Myers Squib, Merck and Co., Allergen.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 OTC Cough and Cold and Allergy Medicine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 OTC Cough and Cold and Allergy Medicine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 OTC Cough and Cold and Allergy Medicine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the OTC Cough and Cold and Allergy Medicine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global OTC Cough and Cold and Allergy Medicine Market Size & Forecast, 2018-2028
4.5.1 OTC Cough and Cold and Allergy Medicine Market Size and Y-o-Y Growth
4.5.2 OTC Cough and Cold and Allergy Medicine Market Absolute $ Opportunity
Chapter 5 Global OTC Cough and Cold and Allergy Medicine Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 OTC Cough and Cold and Allergy Medicine Market Size Forecast by Type
5.2.1 Antihistamine
5.2.2 Expectorants
5.2.3 Bronchodialators
5.2.4 Antibiotics
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global OTC Cough and Cold and Allergy Medicine Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 OTC Cough and Cold and Allergy Medicine Market Size Forecast by Applications
6.2.1 Online
6.2.2 Offline
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global OTC Cough and Cold and Allergy Medicine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 OTC Cough and Cold and Allergy Medicine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America OTC Cough and Cold and Allergy Medicine Analysis and Forecast
9.1 Introduction
9.2 North America OTC Cough and Cold and Allergy Medicine Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America OTC Cough and Cold and Allergy Medicine Market Size Forecast by Type
9.6.1 Antihistamine
9.6.2 Expectorants
9.6.3 Bronchodialators
9.6.4 Antibiotics
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America OTC Cough and Cold and Allergy Medicine Market Size Forecast by Applications
9.10.1 Online
9.10.2 Offline
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe OTC Cough and Cold and Allergy Medicine Analysis and Forecast
10.1 Introduction
10.2 Europe OTC Cough and Cold and Allergy Medicine Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe OTC Cough and Cold and Allergy Medicine Market Size Forecast by Type
10.6.1 Antihistamine
10.6.2 Expectorants
10.6.3 Bronchodialators
10.6.4 Antibiotics
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe OTC Cough and Cold and Allergy Medicine Market Size Forecast by Applications
10.10.1 Online
10.10.2 Offline
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific OTC Cough and Cold and Allergy Medicine Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific OTC Cough and Cold and Allergy Medicine Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific OTC Cough and Cold and Allergy Medicine Market Size Forecast by Type
11.6.1 Antihistamine
11.6.2 Expectorants
11.6.3 Bronchodialators
11.6.4 Antibiotics
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific OTC Cough and Cold and Allergy Medicine Market Size Forecast by Applications
11.10.1 Online
11.10.2 Offline
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America OTC Cough and Cold and Allergy Medicine Analysis and Forecast
12.1 Introduction
12.2 Latin America OTC Cough and Cold and Allergy Medicine Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America OTC Cough and Cold and Allergy Medicine Market Size Forecast by Type
12.6.1 Antihistamine
12.6.2 Expectorants
12.6.3 Bronchodialators
12.6.4 Antibiotics
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America OTC Cough and Cold and Allergy Medicine Market Size Forecast by Applications
12.10.1 Online
12.10.2 Offline
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) OTC Cough and Cold and Allergy Medicine Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) OTC Cough and Cold and Allergy Medicine Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) OTC Cough and Cold and Allergy Medicine Market Size Forecast by Type
13.6.1 Antihistamine
13.6.2 Expectorants
13.6.3 Bronchodialators
13.6.4 Antibiotics
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) OTC Cough and Cold and Allergy Medicine Market Size Forecast by Applications
13.10.1 Online
13.10.2 Offline
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 OTC Cough and Cold and Allergy Medicine Market: Competitive Dashboard
14.2 Global OTC Cough and Cold and Allergy Medicine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sanofi-Aventis
14.3.2 Johnson and Johnson
14.3.3 Reckitt Benckiser Group
14.3.4 Novartis
14.3.5 GlaxoSmithKline
14.3.6 AstraZaneca
14.3.7 Pfizer
14.3.8 Sun Pharmaceutical Industries
14.3.9 Prestige Brands Holdings
14.3.10 Procter and Gamble
14.3.11 Bristol-Myers Squib
14.3.12 Merck and Co.
14.3.13 Allergen
